Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Published Mar 18, 2023

Length 147 Pages

SKU # IMRC17854400

Description

Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Market Overview:

The global acne drugs market size reached US$ 6.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.

Acne drugs refer to the medications used for treating a dermatological infection characterized by the inflammation in the hair follicles on skin. It is usually caused by hormonal imbalance, oily skin, accumulation of dead skin cells, bacteria, stress, inadequate intake of water and excessive consumption of sugars, salts or carbohydrates. Some of the commonly used acne drugs include topical medications, such as retinoids, salicylic and azelaic acid-based ointments and dapsone-based gels, along with antibiotics, anti-androgen agents and isotretinoin. These drugs minimize the levels of oil production in the body, speed up skin cell turnover, control acne breakouts, reduce scarring and damage to the skin and prevent inflammation.

The increasing prevalence of skin-related diseases, such as acne vulgaris, is one of the key factors driving the growth of the market. Moreover, rising awareness among the masses regarding the benefits of using premium skin care products is driving the market growth. The market is further being driven by the development of effective therapeutics and treatment alternatives with reduced side effects and high potential. Increasing consumer preference for products manufactured using natural ingredients is acting as another growth-inducing factor. Manufacturers are, therefore, developing products infused with natural herbs and organic ingredients, such as aloe vera, green tea, honey, jojoba oil and rosemary, for treating acne. Other factors, including rising expenditure capacities of consumers, along with the proliferation of online retail platforms that offer customized acne drugs according to the user’s skin type, are expected to create a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global acne drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on acne type, drug class, drug type and route of administration.

Breakup by Acne Type:

Comedonal
Inflammatory
Cystic
Postsurgical/Wound

Breakup by Drug Class:

Retinoids
Antibiotics
Hormonal Agents
Combination Drugs
Others

Breakup by Drug Type:

OTC Drugs
Prescription Drugs

Breakup by Route of Administration:

Topical
Oral
Injectable

Breakup by Region:

North America

United States
Canada

Asia Pacific

China
Japan
India
South Korea
Australia
Indonesia
Others

Europe

Germany
France
United Kingdom
Italy
Spain
Russia
Others

Latin America

Brazil
Mexico
Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Allergan Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, Cipher Pharmaceuticals Inc., Galderma Holding SA, Johnson & Johnson, Pfizer Inc., Reckitt Benckiser Group Plc, Skinvisible Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

How has the global acne drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global acne drugs market?
What are the key regional markets?
What is the breakup of the market based on the acne type?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the route of administration?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global acne drugs market and who are the key players?
What is the degree of competition in the industry?

1 Preface
2 Scope and Methodology: 2.1 Objectives of the Study; 2.2 Stakeholders; 2.3 Data Sources; 2.3.1 Primary Sources; 2.3.2 Secondary Sources; 2.4 Market Estimation; 2.4.1 Bottom-Up Approach; 2.4.2 Top-Down Approach; 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction: 4.1 Overview; 4.2 Key Industry Trends
5 Global Acne Drugs Market: 5.1 Market Overview; 5.2 Market Performance; 5.3 Impact of COVID-19; 5.4 Market Forecast
6 Market Breakup by Acne Type: 6.1 Comedonal; 6.1.1 Market Trends; 6.1.2 Market Forecast; 6.2 Inflammatory; 6.2.1 Market Trends; 6.2.2 Market Forecast; 6.3 Cystic; 6.3.1 Market Trends; 6.3.2 Market Forecast; 6.4 Postsurgical/Wound; 6.4.1 Market Trends; 6.4.2 Market Forecast
7 Market Breakup by Drug Class: 7.1 Retinoids; 7.1.1 Market Trends; 7.1.2 Market Forecast; 7.2 Antibiotics; 7.2.1 Market Trends; 7.2.2 Market Forecast; 7.3 Hormonal Agents; 7.3.1 Market Trends; 7.3.2 Market Forecast; 7.4 Combination Drugs; 7.4.1 Market Trends; 7.4.2 Market Forecast; 7.5 Others; 7.5.1 Market Trends; 7.5.2 Market Forecast
8 Market Breakup by Drug Type: 8.1 OTC Drugs; 8.1.1 Market Trends; 8.1.2 Market Forecast; 8.2 Prescription Drugs; 8.2.1 Market Trends; 8.2.2 Market Forecast
9 Market Breakup by Route of Administration: 9.1 Topical; 9.1.1 Market Trends; 9.1.2 Market Forecast; 9.2 Oral; 9.2.1 Market Trends; 9.2.2 Market Forecast; 9.3 Injectable; 9.3.1 Market Trends; 9.3.2 Market Forecast
10 Market Breakup by Region: 10.1 North America; 10.1.1 United States; 10.1.1.1 Market Trends; 10.1.1.2 Market Forecast; 10.1.2 Canada; 10.1.2.1 Market Trends; 10.1.2.2 Market Forecast; 10.2 Asia Pacific; 10.2.1 China; 10.2.1.1 Market Trends; 10.2.1.2 Market Forecast; 10.2.2 Japan; 10.2.2.1 Market Trends; 10.2.2.2 Market Forecast; 10.2.3 India; 10.2.3.1 Market Trends; 10.2.3.2 Market Forecast; 10.2.4 South Korea; 10.2.4.1 Market Trends; 10.2.4.2 Market Forecast; 10.2.5 Australia; 10.2.5.1 Market Trends; 10.2.5.2 Market Forecast; 10.2.6 Indonesia; 10.2.6.1 Market Trends; 10.2.6.2 Market Forecast; 10.2.7 Others; 10.2.7.1 Market Trends; 10.2.7.2 Market Forecast; 10.3 Europe; 10.3.1 Germany; 10.3.1.1 Market Trends; 10.3.1.2 Market Forecast; 10.3.2 France; 10.3.2.1 Market Trends; 10.3.2.2 Market Forecast; 10.3.3 United Kingdom; 10.3.3.1 Market Trends; 10.3.3.2 Market Forecast; 10.3.4 Italy; 10.3.4.1 Market Trends; 10.3.4.2 Market Forecast; 10.3.5 Spain; 10.3.5.1 Market Trends; 10.3.5.2 Market Forecast; 10.3.6 Russia; 10.3.6.1 Market Trends; 10.3.6.2 Market Forecast; 10.3.7 Others; 10.3.7.1 Market Trends; 10.3.7.2 Market Forecast; 10.4 Latin America; 10.4.1 Brazil; 10.4.1.1 Market Trends; 10.4.1.2 Market Forecast; 10.4.2 Mexico; 10.4.2.1 Market Trends; 10.4.2.2 Market Forecast; 10.4.3 Others; 10.4.3.1 Market Trends; 10.4.3.2 Market Forecast; 10.5 Middle East and Africa; 10.5.1 Market Trends; 10.5.2 Market Breakup by Country; 10.5.3 Market Forecast
11 SWOT Analysis: 11.1 Overview; 11.2 Strengths; 11.3 Weaknesses; 11.4 Opportunities; 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis: 13.1 Overview; 13.2 Bargaining Power of Buyers; 13.3 Bargaining Power of Suppliers; 13.4 Degree of Competition; 13.5 Threat of New Entrants; 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape: 15.1 Market Structure; 15.2 Key Players; 15.3 Profiles of Key Players; 15.3.1 Allergan Plc; 15.3.1.1 Company Overview; 15.3.1.2 Product Portfolio; 15.3.1.3 Financials; 15.3.1.4 SWOT Analysis; 15.3.2 Bausch Health Companies Inc.; 15.3.2.1 Company Overview; 15.3.2.2 Product Portfolio; 15.3.3 Bayer Aktiengesellschaft; 15.3.3.1 Company Overview; 15.3.3.2 Product Portfolio; 15.3.3.3 Financials; 15.3.3.4 SWOT Analysis; 15.3.4 Cipher Pharmaceuticals Inc.; 15.3.4.1 Company Overview; 15.3.4.2 Product Portfolio; 15.3.4.3 Financials; 15.3.5 Galderma Holding SA; 15.3.5.1 Company Overview; 15.3.5.2 Product Portfolio; 15.3.6 Johnson & Johnson; 15.3.6.1 Company Overview; 15.3.6.2 Product Portfolio; 15.3.6.3 Financials; 15.3.6.4 SWOT Analysis; 15.3.7 Pfizer Inc.; 15.3.7.1 Company Overview; 15.3.7.2 Product Portfolio; 15.3.7.3 Financials; 15.3.7.4 SWOT Analysis; 15.3.8 Reckitt Benckiser Group Plc; 15.3.8.1 Company Overview; 15.3.8.2 Product Portfolio; 15.3.8.3 Financials; 15.3.8.4 SWOT Analysis; 15.3.9 Skinvisible Pharmaceuticals Inc.; 15.3.9.1 Company Overview; 15.3.9.2 Product Portfolio; 15.3.10 Sun Pharmaceutical Industries Limited; 15.3.10.1 Company Overview; 15.3.10.2 Product Portfolio; 15.3.10.3 Financials; 15.3.10.4 SWOT Analysis; 15.3.11 Teva Pharmaceutical Industries Ltd.; 15.3.11.1 Company Overview; 15.3.11.2 Product Portfolio; 15.3.11.3 Financials; 15.3.11.4 SWOT Analysis

Pricing

Currency Rates

Single User Email from Publisher $2,999
Five User License Fulfilled by Publisher $3,999
Global Site License Email from Publisher $4,999

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now